Galderma Group AG Company Description

Galderma Group AG operates as a dermatology company worldwide.

The company delivers a science-based portfolio of brands and services that span the spectrum of the dermatology market, including injectable aesthetics, dermatological skincare, and therapeutic dermatology.

Its portfolio of flagship brands includes Dysport/Azzalure, Alluzience, Restylane, and Sculptra in injectable aesthetics; Cetaphil and Alastin in dermatological skincare; and Soolantra, Epiduo, Differin, Aklief, Epsolay, Twyneo, Oracea, Metvix, Benzac, and Loceryl in therapeutic dermatology.

The company was founded in 1981 and is headquartered in Zug, Switzerland.

Galderma Group AG

Country	Switzerland
Founded	1981
Industry	Pharmaceutical Preparations
Employees	6,545
CEO	Flemming Ornskov

Contact Details

Address: Zählerweg 10 Zug, 6300 Switzerland
Phone	41 58 455 85 92
Website	galderma.com

Stock Details

Ticker Symbol	GALDY
Exchange	OTCMKTS
Fiscal Year	January - December
Reporting Currency	USD
SIC Code	2834

Key Executives

Name	Position
Flemming Ornskov	Chief Executive Officer
Thomas J. Dittrich	Chief Financial Officer
Adrian Murphy	Chief Operating Officer
Emil Ivanov	Head of Investor Relations